Estrogenic effects of 17β-aminoestrogens assessed in uteri of rats and mice

European Journal of Pharmacology

Volumn 510, Issue 3, 2005, Pages 235-239

  Lemini, Cristina ^a   Franco, Yanira ^a   Avila, Ma Estela ^a   Jaimez, Ruth ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

17 aminoestrogen; Estradiol; Estrogenic effect; Uterotrophic effect

Indexed keywords

BUTOLAME; ESTRADIOL; ESTROGEN DERIVATIVE; PENTOLAME; PROLAME; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG STRUCTURE; DRY WEIGHT; ESTROGEN ACTIVITY; FEMALE; IMMATURITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; UTERUS WEIGHT;

EID: 14844323156     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.01.028     Document Type: Article

References (15)

1. M. Cushman Effects of hormone replacement therapy and estrogen receptor modulators on markers of inflammation and coagulation Am. J. Cardiol. 90 2002 7F 10F (Suppl.)
2. J.M. Fernández-G., M.F. Rubio-Arroyo, M. Soriano-García, R.A. Toscano, M.C. Pérez-César, C. Rubio-Póo, J.J. Mandoki, A. De la Peña, C. Lemini, N. Mendoza-Patiño, and F. Cruz Synthesis and molecular structure of prolame, N-(3-hydroxy-1,3,5(10)-estratrien-17β- yl)-3-hydroxypropylamine: an amino-estrogen with prolonged anticoagulant and brief estrogenic effects Steroids 45 1985 151 157
3. E.V. Gembitskii, and A.B. Begunov Changes in parameters of the coagulation and fibrinolysis system of the blood in patients with prostate cancer in the framework of estrogen therapy Klin. Med. (Mosk.) 72 1994 30 32
4. T. Gordon, W.B. Kanell, M.C. Hjortland, and P.M. McNamara Menopause and coronary heart disease. The Framingham study Am. Intern. Med. 89 1978 157 161
5. B.E. Henderson, A. Paganini-Hill, and R.K. Ross Estrogen replacement therapy and protection from acute myocardial infarction Am. J. Obstet. Gynecol. 159 1988 312 317
6. R. Jaimez, A. Coney, K. Jackson, A.E. Lemus, C. Lemini, M. Cárdenas, R. García, G. Silva, and F. Larrea In vivo estrogen bioactivities and in vitro estrogen receptor binding and transcriptional activities of anticoagulant synthetic 17β-aminoestrogens J. Steroid Biochem. Mol. Biol. 73 2000 59 66
7. M.F. Kalin, and B. Zumoff Sex hormones and coronary disease: a review of the clinical studies Steroids 55 1990 330 352
8. C. Lemini, C. Rubio-Poó, G. Silva, J. García- Mondragón, E. Zavala, N. Mendoza-Patiño, D. Castro, R. Cruz-Almanza, and J.J. Mandoki Anticoagulant and estrogenic effects of two new 17β-aminoestrogens, butolame [17β-(4-hydroxy-1-butylamino)-1,3,5(10)- estratrien-3-ol] and pentolame [17β-(5-hydroxy-1-pentylamino)-1,3,5(10)- estratrien-3-ol] Steroids 58 1993 457 461
9. A.E. Lemus, R. Jaimez, C. Lemini, M. Menjívar, G. Silva, C. Rubio-Póo, F. Valenzuela, and F. Larrea Estrogenic effects of the synthetic aminoestrogen 17β-(5-hydroxy-1-pentylamino)-1,3,5(10)-estratrien- 3-ol (pentolame) Steroids 63 1998 433 438
10. E.F. Mammen Oral contraceptives pills and hormonal replacement therapy and thromboembolic disease Hematol./Oncol. Clin. North Am. 13 2000 1045 1059
11. FR. Rosendaal, F.M. Helmerhorst, and J.P. Vandenbroucke Oral contraceptives, hormone replacement therapy and thrombosis Thromb. Haemost. 86 2001 112 123
12. F.R. Rosendaal, F.M. Helmerhorst, and J.P. Vandenbroucke Female hormones and thrombosis Arterioscler. Thromb. Vasc. Biol. 22 2002 201 210
13. C. Rubio-Póo, C. Lemini, G. Silva, B. Chavez-Lara, N. Mendoza-Patiño, R. Ortíz, and J.J. Mandoki Effects of 17β-(N,N-diethylaminoethyl)-amino-1,3,5(10)-estratrien-3-ol, and its androstane analog on blood clotting time Med. Chem. Res. 7 1993 67 75
14. B.G. Wren The effect of oestrogen on the female cardiovascular system Med. J. Aust. 157 1992 204 208
15. J.H. Zar Biostatistical analysis B.N.J. Kurts Multiple comparisons second ed. 1984 Prentice-Hall Englewood Cliffs. NJ 194 195